ArticleFrontiers in oncology2025
Feasibility study of U-Net-based automatic segmentation of pelvic bone marrow for postoperative radiotherapy in cervical cancer.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the feasibility and clinical value of RT-Mind, a convolutional neural network (CNN)-based auto-segmentation software, in delineating clinical target volume (CTV) and pelvic bone marrow (PBM) as organs at risk (OARs) during postoperative radiotherapy for cervical cancer. Methods: A retrospective analysis was conducted on 55 cervical cancer patients who underwent postoperative radiotherapy between March 2024 and January 2025. Manual delineations by experienced radiation oncologists were compared with auto-segmentations generated by RT-Mind for CTV and OARs (including rectum, bladder, bowel bag, femoral heads, and bone marrow). Evaluation metrics included Dice Similarity Coefficient (DSC), Hausdorff Distance (HD), Jaccard Index (JAC), and Sensitivity Index (SI), along with time efficiency comparisons between manual and automatic contouring. Results: The auto-segmentation achieved favorable accuracy across multiple structures. For bone marrow, the DSC, HD, JAC, and SI were 0.89 ± 0.05, (2.39 ± 0.90) mm, 0.80 ± 0.11, and 0.87 ± 0.04, respectively. Bladder and femoral heads also showed high concordance, with DSCs exceeding 0.91 and HDs below 2 mm. Auto-segmentation significantly reduced contouring time across all structures; for CTV, the average time decreased from (4151.54 ± 300.23) seconds to(45.82 ± 2.00)seconds (t=-102.10,p< 0.001).From a dosimetric perspective, auto-segmentation achieved comparable CTV coverage to manual methods (P > 0.05), but showed statistically significant improvements in organ-at-risk sparing for bone marrow, small bowel, and rectum (P< 0.05). No clinically relevant differences were detected for bladder or femoral head doses. Conclusion: The RT-Mind software based on a U-Net architecture demonstrates high accuracy and efficiency in segmenting CTV and OARs in postoperative radiotherapy for cervical cancer, particularly in delineating pelvic bone marrow. It effectively reduces contouring time and inter-observer variability, offering promising clinical applicability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.